Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells

Although gemcitabine (GEM) is frequently used in the treatment of pancreatic cancer, the effects are limited. To increase the inhibitory effect of GEM, the identification of a molecular target is needed. Recent studies have revealed that doublecortin-like kinase 1 (Dclk1) positively regulates tumor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology reports 2017-11, Vol.38 (5), p.3238-3244
Hauptverfasser: Kawamura, Daichi, Takemoto, Yoshihiro, Nishimoto, Arata, Ueno, Koji, Hosoyama, Tohru, Shirasawa, Bungo, Tanaka, Toshiki, Kugimiya, Naruji, Harada, Eijiro, Hamano, Kimikazu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!